Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)

NCT00508664 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Hypopharynx
Larynx Carcinoma

Interventions

RADIATION: Radiation
DRUG: Cetuximab
DRUG: Docetaxel
DRUG: Cisplatin (TP)
DRUG: 5-Fluorouracil (TPF) (only until Feb 2009)

Sponsor

ClinAssess

Collaborators

[object Object]
[object Object]